ProMIS Neurosciences, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

FAIR VALUE MEASUREMENTS (Tables)

FAIR VALUE MEASUREMENTS (Tables)

6 Months Ended

Jun. 30, 2024

FAIR VALUE MEASUREMENTS

Summary of major categories of assets and liabilities measured at fair value on a recurring basis


		As of June 30, 2024
		Level 1			Level 2				Level 3		Total
Assets:
Short-term investments		$	32,358		$	—		$	—		$	32,358
Total assets measured at fair value		$	32,358		$	—		$	—		$	32,358
Liabilities:
Share-based compensation liability		$	—		$	—		$	465,488		$	465,488
Warrant liability		$	—		$	—		$	49,231		$	49,231
Total liabilities measured at fair value		$	—		$	—		$	514,719		$	514,719


		As of December 31, 2023
		Level 1			Level 2				Level 3		Total
Assets:
Short-term investments		$	32,358		$	—		$	—		$	32,358
Total assets measured at fair value		$	32,358		$	—		$	—		$	32,358
Liabilities:
Share-based compensation liability		$	—		$	—		$	422,002		$	422,002
Warrant liability			—			—			94,185			94,185
Total liabilities measured at fair value		$	—		$	—		$	516,187		$	516,187